查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1372865

診斷影像市場 - 2018-2028 年全球產業規模、佔有率、趨勢、機會和預測，按產品類型、按應用、最終用戶、地區和競爭細分

Diagnostic Imaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028 Segmented By Product Type, By Application, By End User, By Region and Competition
出版日期: | 出版商: TechSci Research | 英文 182 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2022年，全球診斷影像市場估值達250.9億美元，預計在預測期內將顯著成長，預計到2028年年複合成長率(CAGR)為5.53%。

診斷影像包括多種用於視覺化人體的技術，是診斷、監測和治療醫療狀況的重要工具。每種影像方式都能提供對目標身體部位的獨特見解，包括疾病、損傷的檢測或醫療介入有效性的評估。這些用於捕捉體內結構的非侵入性方法統稱為診斷影像，涵蓋 X 光、磁振造影 (MRI)、電腦斷層掃描 (CT)、產前診斷和其他專門模式等技術。

醫療保健專業人員利用診斷影像的力量來建立精確的診斷並進行全面的患者評估。此外，這項技術在密切監測患者對治療方案和藥物的反應方面發揮著至關重要的作用。診斷影像涵蓋廣泛的程序，使醫療保健提供者能夠獲得對身體內部結構的寶貴視覺洞察，最終有助於準確識別健康問題或傷害的根本原因。

市場概況
預測期 2024-2028
2022 年市場規模 250.9億美元
2028 年市場規模 349億美元
2023-2028 年年複合成長率 5.53%
成長最快的細分市場 腫瘤學
最大的市場 北美洲

主要市場促進因素

慢性病盛行率上升

慢性病盛行率的上升預計將顯著增加未來對診斷影像的需求。這種上升趨勢是由幾個相互關聯的因素推動的，這些因素強調了影像技術在慢性健康狀況的診斷和管理中的關鍵作用。

更多採用診斷成像中的先進技術

診斷影像中先進技術的日益採用將顯著增加未來對診斷影像的需求。這一趨勢是由多種因素推動的，這些因素強調了尖端技術在增強醫療診斷和患者護理方面的關鍵作用。這項需求的關鍵促進因素之一是人工智慧 (AI) 和機器學習演算法的持續開發和整合到診斷成像流程中。這些人工智慧驅動的系統有潛力加快並提高影像分析的準確性，幫助醫療保健專業人員進行早期疾病檢測、診斷和治療計劃。人工智慧可以幫助識別醫學影像中的微妙模式或異常，使診斷過程更有效率和有效。

此外，3D 和 4D 影像技術（例如 3D 乳房 X 光攝影和 4D 胎兒超音波）的出現徹底改變了診斷影像領域。這些技術提供了解剖結構和生理過程的更詳細和動態的視圖，為臨床醫生的診斷和治療提供了寶貴的見解。隨著這些先進成像方式變得更容易獲得和負擔得起，對它們的需求預計會增加。診斷成像領域擴大採用先進技術，有望透過提高診斷準確性、可及性和便利性來徹底改變該領域。隨著這些技術變得更加廣泛並融入醫療保健系統，對診斷成像的需求預計將會上升，最終導致未來患者護理和結果的改善。

老年人口的增加

老年人口的增加預計將顯著增加未來對診斷影像的需求。這種人口結構變化是由預期壽命延長和出生率下降所推動的，導致全球老年人口不斷增加。老化過程帶來了各種慢性疾病和與年齡相關的疾病的可能性更高，這需要增加診斷影像服務。

隨著個體年齡的成長，心血管疾病、癌症、骨關節炎和神經系統疾病等慢性疾病的風險也會增加。診斷影像在這些疾病的早期檢測、疾病監測和治療計劃中發揮著至關重要的作用。定期篩檢和影像學檢查對於有效管理老年族群的健康至關重要。老年人經常患有複雜的醫療狀況，需要採用多學科方法進行診斷和治療。 MRI、CT 掃描和 PET 掃描等先進影像技術可提供對這些疾病的詳細、全面的了解，幫助醫療保健提供者做出準確的診斷並針對個別患者制定治療方案。

不斷成長的老年人口是未來診斷影像需求增加的重要驅動力。隨著老年人口不斷擴大，醫療保健系統必須做好準備，以滿足對先進影像服務不斷成長的需求，以促進早期診斷、提高治療效果並提高老年人的整體護理品質。

引進技術先進的系統

由於對慢性病早期和具有成本效益的診斷的需求不斷增加以及全球人口老化等因素，對診斷影像設備的需求預計將顯著成長。影響市場成長的兩個關鍵促進因素是技術先進設備的引進和亞洲國家醫療保健產業的擴張。例如，富士軟片公司於2020年5月推出了一種新的基於人工智慧（AI）的肺結節檢測技術。該技術透過檢測胸部CT掃描中的肺結節來幫助診斷肺癌。

此外，2020年11月，佳能醫療系統公司推出了單次心跳光譜心臟CT，可在一次心跳中捕捉整個心臟的光譜影像。該技術結合了快速 kVp 切換和深度學習光譜重建。各種創新產品的推出預計將推動需求並促進市場的成長。

主要市場挑戰

昂貴的程序和設備

與昂貴的程序和設備相關的成本阻礙了對診斷影像的需求，這給醫療保健系統、提供者和患者帶來了重大挑戰。取得和維護先進影像設備（例如 MRI 機器、CT 掃描儀和 PET 掃描儀）的高昂成本給醫療機構帶來了相當大的財務負擔。這些機構經常透過增加影像服務費用將這些成本轉嫁給患者，使沒有足夠保險或經濟能力的個人更難獲得這些服務。某些影像程序的複雜性需要對技術人員和放射科醫生進行專門培訓，這會增加勞動成本。一些地區合格人員的稀缺性進一步加劇了這個問題，導致影像預約的等待時間更長並導致診斷延遲。

與診斷影像程序和設備相關的高成本阻礙了他們的需求，可能限制許多患者獲得重要的醫療診斷。應對這項挑戰需要創新方法，例如公私合作夥伴關係、研究具有成本效益的影像技術以及改善保險覆蓋範圍，以確保患者能夠獲得所需的診斷影像服務，而不會陷入過度的經濟困難。這對於及時準確的診斷以及醫療保健結果的整體改善至關重要。

維護和升級成像設備的經常性費用

另一個因素是維護和升級影像設備以確保其準確性並符合不斷發展的醫療保健標準的經常性成本。診斷影像設備，例如 MRI 機器、CT 掃描儀和超音波設備，需要定期維護以確保其正常功能和準確性。日常維護、校準和維修對於保持影像品質和可靠性是必要的。維護一系列複雜的影像設備的成本可能很高，會耗盡醫療機構的財務資源。

這些持續的成本可能會使醫療機構猶豫是否要投資新的影像技術，並可能限制某些地區或設施獲得最先進的影像服務。維護和升級成像設備的經常性成本所帶來的財務限制可能會導致多種不利後果，包括成像預約的等待時間更長、獲得尖端診斷技術的機會有限，以及醫療保健提供者尋求收回成本時可能會增加病人的成本他們的開支。

主要市場趨勢

照護端成像

更小型、攜帶式和床邊成像設備的發展使得在緊急情況、救護車和偏遠地區更容易進行診斷成像，從而減少了對集中成像設施的需求。在緊急情況下，例如創傷病例或中風事件，及時診斷對於患者的治療結果至關重要。攜帶式影像設備使醫療專業人員能夠在現場快速評估受傷、內出血或神經系統狀況，從而促進有關治療方案的快速決策。救護車配備攜帶式影像設備，使護理人員和緊急醫療人員能夠在前往醫院的途中進行初步掃描和診斷。這些即時資訊可以幫助醫院為即將到來的患者做好準備，並在患者抵達後採取適當的干涉措施。

在無法獲得集中醫療設施的偏遠或服務不足的地區，攜帶式影像設備可以為患者所在位置提供診斷功能。這對於否則在接受及時和全面的醫療服務方面將面臨挑戰的社區尤其重要。

先進的成像方式

正子斷層掃描 (PET)-MRI 和混合成像技術等影像方法的不斷進步，為改進診斷提供了更全面、更詳細的資訊。 PET-MRI 將 PET 掃描的功能和代謝資訊與 MRI 掃描的詳細解剖資訊結合。這種同步成像在一次掃描中提供了身體結構和功能的整體視圖，從而可以進行更準確和全面的評估。傳統的 PET-CT 掃描區分不同軟組織的能力有限。另一方面，PET-MRI 在軟組織對比方面表現出色，可以檢測大腦、肝臟和前列腺等器官的細微異常，這使其在腫瘤學和神經學方面具有無價的價值。

與 PET-CT 相比，PET-MRI 減少了輻射暴露，這對於兒科患者和需要多次掃描的個人特別有利。較低的輻射劑量還可以最大限度地減少與輻射暴露相關的潛在長期風險。

細分市場洞察

產品類型見解

根據產品類型，市場分為 X 光成像系統、電腦斷層掃描 (CT) 掃描儀、超音波成像系統、磁振造影 (MRI) 系統和核子成像系統。 X 光成像系統因其低成本且能夠產生準確的影像而引領診斷成像市場，從而提供肌肉骨骼系統的清晰概念。這對於診斷骨折、骨骼疾病和關節異常特別有益。

對行動 X 光系統不斷成長的需求進一步支持了 X 光成像系統領域的成長，行動 X 光系統可以在各種醫療保健環境中方便地進行成像。此外，醫院和診斷中心數量的不斷增加，特別是在新興國家，也促進了這個市場的成長。數位技術的進步也提高了 X 光成像的品質和效率，使其成為許多醫療保健專業人員的首選。推動 X 光成像系統發展的另一個因素是該過程的無痛性和非侵入性。患者發現 X 光檢查相對舒適且快捷，從而提高了患者滿意度。此外，與 MRI 和 CT 掃描儀等其他方式相比，X 光通常更便宜，這使得預算有限的醫療機構更容易使用它們。總體而言，X 光技術的持續進步，加上其成本效益和診斷準​​確性，有助於 X 光成像系統在診斷成像市場中佔據主導地位。

最終使用者見解

根據最終用戶，市場分為醫院、診斷影像中心和門診影像中心。目前，醫院所佔比例最大。然而，在預測期內，診斷中心對影像系統的採用預計將以最高的年複合成長率(CAGR) 成長。這可以歸因於幾個因素，包括由於診斷成像程序的需求不斷成長而推動私人成像中心數量的增加。這個最終用戶細分市場的成長預計將受到準確和及時診斷的需求以及成像技術進步的推動，從而實現更好的可視化和改善患者的治療結果。隨著人們越來越關注疾病的早期發現和預防，診斷影像中心在提供高品質醫療保健服務方面的作用變得越來越重要。

區域洞察

2022年，北美成為醫療/診斷影像市場的主導者，佔據了主要佔有率。憑藉完善的醫療保健基礎設施和醫療成像外包主要參與者的存在，該地區預計將在預測期內保持其在全球醫療成像市場的主導地位。這可以歸因於慢性病的盛行率不斷增加，從而導致對先進診斷影像技術的需求不斷成長。

另一方面，預計2024年至2028年亞太地區將呈現最高的年複合成長率（CAGR）。這可歸因於多種因素，包括醫院數量的快速增加、早期診斷需求的不斷成長，以及癌症和心臟病等疾病的日益普及。此外，該地區老年人口數量大幅增加，進一步推動了對醫學影像服務的需求。總體而言，這些趨勢顯示醫學影像市場充滿活力且不斷發展，北美將保持其據點，而亞太地區將成為未來幾年的關鍵成長區域。

目錄

第 1 章：產品概述

  • 市場定義
  • 市場範圍
    • 涵蓋的市場
    • 研究年份
    • 主要市場區隔

第 2 章：研究方法

  • 研究目的
  • 基線方法
  • 主要產業夥伴
  • 主要協會和二手資料來源
  • 預測方法
  • 數據三角測量與驗證
  • 假設和限制

第 3 章：執行摘要

  • 市場概況
  • 主要市場細分概述
  • 主要市場參與者概述
  • 重點地區/國家概況
  • 市場促進因素、挑戰、趨勢概述

第 4 章：客戶之聲

第 5 章：全球診斷影像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型（X 光、超音波、電腦斷層掃描、核子造影和磁振造影）
    • 按應用（腫瘤科、神經科、心臟科、婦科、骨科等）
    • 按最終用戶（醫院、診斷影像中心和門診影像中心）
    • 按地區
    • 按公司分類 (2022)
  • 市場地圖

第 6 章：北美診斷影像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 北美：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第 7 章：歐洲診斷影像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 歐洲：國家分析
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙

第 8 章：亞太地區診斷影像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第 9 章：南美洲診斷影像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • 南美洲：國家分析
    • 巴西
    • 阿根廷
    • 哥倫比亞

第 10 章：中東和非洲診斷影像市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依產品類型
    • 按應用
    • 按最終用戶
    • 按國家/地區
  • MEA：國家分析
    • 南非診斷影像
    • 沙烏地阿拉伯診斷成像
    • 阿拉伯聯合大公國診斷成像

第 11 章：市場動態

  • 促進要素
  • 挑戰

第 12 章：市場趨勢與發展

  • 近期發展
  • 併購
  • 產品發布

第 13 章：全球診斷影像市場：SWOT 分析

第 14 章：波特的五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商的力量
  • 客戶的力量
  • 替代產品的威脅

第15章：競爭格局

  • 商業概覽
  • 服務內容
  • 最近的發展
  • 主要人員
  • SWOT分析
    • GE Healthcare Inc.
    • Philips Healthcare Informatics Inc.
    • Hitachi Medical Corporation
    • Hologic, Inc.
    • Siemens Healthcare GmbH
    • Samsung Medison
    • Shimadzu Corporation
    • Toshiba Medical Systems Corporation
    • Esaote SPA
    • Fujifilm Corporation

第 16 章：策略建議

第 17 章：關於我們與免責聲明

簡介目錄
Product Code: 4950

In 2022, the Global Diagnostic Imaging Market reached a valuation of USD 25.09 billion, and it is poised for remarkable growth in the forecast period with a projected Compound Annual Growth Rate (CAGR) of 5.53% through 2028.

Diagnostic imaging comprises a diverse array of techniques utilized to visualize the human body, serving as a vital tool in the diagnosis, monitoring, and treatment of medical conditions. Each imaging modality offers distinct insights into the targeted body part, including the detection of diseases, injuries, or the assessment of the effectiveness of medical interventions. These non-invasive methods for capturing internal body structures, collectively referred to as diagnostic imaging, encompass technologies such as X-rays, magnetic resonance imaging (MRI), computed tomography (CT), prenatal diagnostics, and other specialized modalities.

Healthcare professionals harness the power of diagnostic imaging to establish precise diagnoses and conduct comprehensive patient assessments. Moreover, this technology plays a crucial role in closely monitoring a patient's response to treatment regimens and medications. Diagnostic imaging encompasses a wide range of procedures, enabling healthcare providers to gain valuable visual insights into the body's internal structures, ultimately aiding in the accurate identification of the root causes of health issues or injuries.

Market Overview
Forecast Period2024-2028
Market Size 2022USD 25.09 Billion
Market Size 2028USD 34.90 Billion
CAGR 2023-20285.53%
Fastest Growing SegmentOncology
Largest MarketNorth America

Key Market Drivers

Rise in the Prevalence of Chronic Diseases

The rise in the prevalence of chronic diseases is expected to significantly increase the demand for diagnostic imaging in the future. This upward trend is driven by several interconnected factors that underscore the critical role of imaging technologies in the diagnosis and management of chronic health conditions.

Chronic diseases, such as cardiovascular disease, cancer, diabetes, and respiratory disorders, are becoming increasingly common worldwide due to factors like aging populations, sedentary lifestyles, and dietary habits. These conditions often require precise and early diagnosis to initiate effective treatments and improve patient outcomes. Diagnostic imaging techniques like X-rays, CT scans, MRIs, and ultrasound play a pivotal role in detecting and monitoring these diseases, allowing healthcare providers to make informed decisions about patient care. Diagnostic imaging helps tailor treatment plans to individual patient needs, allowing for more effective and less invasive interventions. For example, cancer imaging techniques help oncologists precisely locate tumors, assess their stage, and monitor treatment response, all of which contribute to better treatment outcomes.

Increased Adoption of Advanced Technologies in Diagnostic imaging

The increased adoption of advanced technologies in diagnostic imaging is poised to significantly boost the demand for diagnostic imaging in the future. This trend is driven by a convergence of factors that underscore the pivotal role of cutting-edge technologies in enhancing healthcare diagnostics and patient care. One of the key drivers of this demand is the continuous development and integration of artificial intelligence (AI) and machine learning algorithms into diagnostic imaging processes. These AI-driven systems have the potential to expedite and improve the accuracy of image analysis, aiding healthcare professionals in early disease detection, diagnosis, and treatment planning. AI can assist in identifying subtle patterns or abnormalities in medical images, making the diagnostic process more efficient and effective.

Furthermore, the advent of 3D and 4D imaging techniques, such as 3D mammography and 4D fetal ultrasound, has revolutionized the field of diagnostic imaging. These technologies provide more detailed and dynamic views of anatomical structures and physiological processes, offering clinicians invaluable insights for diagnosis and treatment. The demand for these advanced imaging modalities is expected to increase as they become more accessible and affordable. The increased adoption of advanced technologies in diagnostic imaging promises to revolutionize the field by enhancing diagnostic accuracy, accessibility, and convenience. As these technologies become more widespread and integrated into healthcare systems, the demand for diagnostic imaging is expected to rise, ultimately leading to improved patient care and outcomes in the future.

Increase in the Geriatric Population

The increase in the geriatric population is expected to significantly drive up the demand for diagnostic imaging in the future. This demographic shift is driven by longer life expectancies and declining birth rates, resulting in a growing elderly population worldwide. The aging process brings with it a higher likelihood of developing various chronic diseases and age-related conditions, which necessitate increased diagnostic imaging services.

As individuals age, their risk of developing chronic illnesses such as cardiovascular disease, cancer, osteoarthritis, and neurological disorders rises. Diagnostic imaging plays a crucial role in early detection, disease monitoring, and treatment planning for these conditions. Regular screenings and imaging tests are essential for managing the health of the elderly population effectively. Older adults often present with complex medical conditions that require a multidisciplinary approach to diagnosis and treatment. Advanced imaging technologies like MRI, CT scans, and PET scans provide detailed and comprehensive insights into these conditions, aiding healthcare providers in making accurate diagnoses and tailoring treatments to individual patients.

The growing geriatric population is a significant driver of increased demand for diagnostic imaging in the future. As the elderly population continues to expand, healthcare systems must be prepared to meet the rising need for advanced imaging services to facilitate early diagnosis, enhance treatment outcomes, and improve the overall quality of care for older adults.

Introduction of Technologically Advanced Systems

The demand for diagnostic imaging equipment is projected to experience significant growth due to factors such as the increasing need for early and cost-effective diagnoses of chronic diseases and the aging global population. Two key drivers influencing market growth are the introduction of technologically advanced devices and the expansion of the healthcare industry in Asian countries. For example, Fujifilm Corporation introduced a new Artificial Intelligence (AI)-based lung nodule detection technology in May 2020. This technology aids in the diagnosis of lung cancer by detecting pulmonary nodules in chest CT scans.

Furthermore, in November 2020, Canon Medical Systems Corporation introduced the One-Beat Spectral Cardiac CT, which enables the capture of whole-heart spectral images in a single heartbeat. This technology incorporates quick kVp switching and deep learning spectral reconstruction. The introduction of various innovative products is expected to drive demand and contribute to the market's growth.

Key Market Challenges

Expensive Procedures and Equipment

The demand for diagnostic imaging is being hindered by the cost associated with expensive procedures and equipment, posing significant challenges for healthcare systems, providers, and patients alike. The high cost of acquiring and maintaining advanced imaging equipment, such as MRI machines, CT scanners, and PET scanners, places a considerable financial burden on healthcare institutions. These institutions often pass these costs onto patients through increased charges for imaging services, making them less accessible for individuals without adequate insurance coverage or financial means. The complexity of certain imaging procedures necessitates specialized training for technicians and radiologists, which can increase labor costs. The scarcity of qualified personnel in some regions further exacerbates this issue, leading to longer wait times for imaging appointments and delayed diagnoses.

The high costs associated with diagnostic imaging procedures and equipment are hindering their demand, potentially limiting access to crucial medical diagnostics for many patients. Addressing this challenge requires innovative approaches, such as public-private partnerships, research into cost-effective imaging technologies, and improved insurance coverage, to ensure that patients can access the diagnostic imaging services they need without undue financial hardship. This is essential for both timely and accurate diagnoses and the overall improvement of healthcare outcomes.

Recurring Expense of Maintaining and Upgrading Imaging Equipment

Another factor is the recurring expense of maintaining and upgrading imaging equipment to ensure its accuracy and compliance with evolving healthcare standards. Diagnostic imaging equipment, such as MRI machines, CT scanners, and ultrasound devices, require regular maintenance to ensure their proper functionality and accuracy. Routine servicing, calibration, and repairs are necessary to maintain image quality and reliability. The cost of maintaining a fleet of sophisticated imaging devices can be substantial, draining financial resources from healthcare facilities.

These ongoing costs can make healthcare institutions hesitant to invest in new imaging technologies and may limit the accessibility of state-of-the-art imaging services to certain regions or facilities. The financial constraints imposed by the recurring costs of maintaining and upgrading imaging equipment can lead to several adverse consequences, including longer waiting times for imaging appointments, limited access to cutting-edge diagnostic technologies, and potentially higher costs for patients as healthcare providers seek to recoup their expenses.

Key Market Trends

Point-of-Care Imaging

The development of smaller, portable, and point-of-care imaging devices is making diagnostic imaging more accessible in emergency situations, ambulances, and remote areas, reducing the need for centralized imaging facilities. In emergency situations, such as trauma cases or stroke incidents, timely diagnosis is critical for patient outcomes. Portable imaging devices allow medical professionals to quickly assess injuries, internal bleeding, or neurological conditions on-site, facilitating rapid decision-making regarding treatment options. Equipping ambulances with portable imaging devices enables paramedics and emergency medical personnel to perform preliminary scans and diagnostics while en route to the hospital. This real-time information can help hospitals prepare for incoming patients and initiate appropriate interventions upon arrival.

In remote or underserved areas with limited access to centralized healthcare facilities, portable imaging devices bring diagnostic capabilities to the patient's location. This is particularly important for communities that would otherwise face challenges in receiving timely and comprehensive medical care.

Advanced Imaging Modalities

Continuous advancements in imaging modalities, such as positron emission tomography (PET)-MRI and hybrid imaging technologies, offer more comprehensive and detailed information for improved diagnosis. PET-MRI combines the functional and metabolic information from PET scans with the detailed anatomical information from MRI scans. This simultaneous imaging provides a holistic view of the body's structures and functions in a single scan, allowing for more accurate and comprehensive assessments. Traditional PET-CT scans are limited in their ability to distinguish between different soft tissues. PET-MRI, on the other hand, excels in soft tissue contrast and can detect subtle abnormalities in organs like the brain, liver, and prostate, making it invaluable in oncology and neurology.

PET-MRI reduces radiation exposure compared to PET-CT, making it particularly advantageous for pediatric patients and individuals requiring multiple scans over time. The lower radiation dose also minimizes potential long-term risks associated with radiation exposure.

Segmental Insights

Product Type Insights

Based on the product type, the market is segmented into X-ray imaging systems, computed tomography (CT) scanners, ultrasound imaging systems, magnetic resonance imaging (MRI) systems, and nuclear imaging systems. X-ray imaging systems lead the diagnostic imaging market owing to their low cost and the ability to produce accurate images that provide a clear idea of the musculoskeletal system. This is particularly beneficial for diagnosing fractures, bone diseases, and joint abnormalities.

The growth of the X-ray imaging systems segment is further supported by the increasing demand for mobile X-ray systems, which allow for convenient imaging in various healthcare settings. Additionally, the expanding number of hospitals and diagnostic centres, especially in emerging countries, contributes to the growth of this market segment. The advancements in digital technology have also improved the quality and efficiency of X-ray imaging, making it a preferred choice for many healthcare professionals. Another factor driving the growth of X-ray imaging systems is the painless and non-invasive nature of the procedures. Patients find X-ray examinations relatively comfortable and quick, which leads to improved patient satisfaction. Moreover, X-rays are generally more affordable compared to other modalities such as MRI and CT scanners, making them more accessible for healthcare facilities with budget constraints. Overall, the continued advancements in X-ray technology, coupled with its cost-effectiveness and diagnostic accuracy, contribute to the dominance of X-ray imaging systems in the diagnostic imaging market.

End User Insights

Based on the end user, the market is segmented into hospitals, diagnostic imaging centers, and Ambulatory Imaging Centres. Currently, hospitals comprise the largest share. However, the adoption of imaging systems by diagnostic centers is expected to grow at the highest compound annual growth rate (CAGR) during the forecast period. This can be attributed to several factors, including the increasing number of private imaging centers fueled by the rising demand for diagnostic imaging procedures. The growth of this end user segment is expected to be driven by the need for accurate and timely diagnosis, as well as the advancements in imaging technology that enable better visualization and improved patient outcomes. With the increasing focus on early detection and prevention of diseases, the role of diagnostic imaging centers in delivering high-quality healthcare services is becoming increasingly important.

Regional Insights

In 2022, North America emerged as the dominant player in the medical/diagnostic imaging market, capturing a major share. With a well-established healthcare infrastructure and the presence of key players for medical imaging outsourcing, the region is poised to maintain its dominance in the global medical imaging market during the forecast period. This can be attributed to the increasing prevalence of chronic diseases, which has led to a growing demand for advanced diagnostic imaging technologies.

On the other hand, Asia-Pacific is projected to exhibit the highest compound annual growth rate (CAGR) from 2024 to 2028. This can be attributed to several factors, including the rapid increase in the number of hospitals, the rising demand for early diagnosis, and the growing prevalence of diseases such as cancer and cardiac ailments. Additionally, the region is experiencing a significant upsurge in the number of geriatric populations, further driving the demand for medical imaging services. Overall, these trends indicate a dynamic and evolving medical imaging market, with North America maintaining its stronghold and Asia-Pacific emerging as a key growth region in the coming years.

Key Market Players

  • GE Healthcare Inc.
  • Philips Healthcare Informatics Inc.
  • Hitachi Medical Corporation
  • Hologic, Inc.
  • Siemens Healthcare GmbH
  • Samsung Medison
  • Shimadzu Corporation
  • Toshiba Medical Systems Corporation
  • Esaote S.P.A
  • Fujifilm Corporation

Report Scope:

In this report, the Global Diagnostic Imaging Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Diagnostic Imaging Market, By Product Type:

  • X-Ray
  • Ultrasound
  • Computed Tomography
  • Nuclear Imaging
  • Magnetic Resonance Imaging

Diagnostic Imaging Market, By Application:

  • Oncology
  • Neurology
  • Cardiology
  • Gynaecology
  • Orthopaedics
  • Others

Diagnostic Imaging Market, By End User:

  • Hospitals
  • Diagnostic Imaging Centres
  • Ambulatory Imaging Centres

Diagnostic Imaging Market, By Region:

  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
  • Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • South America
  • Brazil
  • Argentina
  • Colombia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait
  • Turkey
  • Egypt

Competitive Landscape

  • Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Imaging Market.

Available Customizations:

  • Global Diagnostic Imaging market report with the given market data, Tech Sci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validations
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Diagnostic Imaging Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Product Type (X-Ray, Ultrasound, Computed Tomography, Nuclear Imaging, and Magnetic Resonance Imaging)
    • 5.2.2. By Application (Oncology, Neurology, Cardiology, Gynaecology, Orthopaedics, and Others)
    • 5.2.3. By End User (Hospitals, Diagnostic Imaging Centres, and Ambulatory Imaging Centres)
    • 5.2.4. By Region
    • 5.2.5. By Company (2022)
  • 5.3. Market Map

6. North America Diagnostic Imaging Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Product Type
    • 6.2.2. By Application
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Diagnostic Imaging Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Product Type
        • 6.3.1.2.2. By Application
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Diagnostic Imaging Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Product Type
        • 6.3.2.2.2. By Application
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Diagnostic Imaging Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Product Type
        • 6.3.3.2.2. By Application
        • 6.3.3.2.3. By End User

7. Europe Diagnostic Imaging Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Product Type
    • 7.2.2. By Application
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Diagnostic Imaging Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Product Type
        • 7.3.1.2.2. By Application
        • 7.3.1.2.3. By End User
    • 7.3.2. United Kingdom Diagnostic Imaging Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Product Type
        • 7.3.2.2.2. By Application
        • 7.3.2.2.3. By End User
    • 7.3.3. Italy Diagnostic Imaging Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecasty
        • 7.3.3.2.1. By Product Type
        • 7.3.3.2.2. By Application
        • 7.3.3.2.3. By End User
    • 7.3.4. France Diagnostic Imaging Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Product Type
        • 7.3.4.2.2. By Application
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Diagnostic Imaging Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Product Type
        • 7.3.5.2.2. By Application
        • 7.3.5.2.3. By End User

8. Asia-Pacific Diagnostic Imaging Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Product Type
    • 8.2.2. By Application
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia-Pacific: Country Analysis
    • 8.3.1. China Diagnostic Imaging Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Product Type
        • 8.3.1.2.2. By Application
        • 8.3.1.2.3. By End User
    • 8.3.2. India Diagnostic Imaging Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Product Type
        • 8.3.2.2.2. By Application
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Diagnostic Imaging Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Product Type
        • 8.3.3.2.2. By Application
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Diagnostic Imaging Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Product Type
        • 8.3.4.2.2. By Application
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Diagnostic Imaging Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Product Type
        • 8.3.5.2.2. By Application
        • 8.3.5.2.3. By End User

9. South America Diagnostic Imaging Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Product Type
    • 9.2.2. By Application
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Diagnostic Imaging Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Product Type
        • 9.3.1.2.2. By Application
        • 9.3.1.2.3. By End User
    • 9.3.2. Argentina Diagnostic Imaging Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Product Type
        • 9.3.2.2.2. By Application
        • 9.3.2.2.3. By End User
    • 9.3.3. Colombia Diagnostic Imaging Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Product Type
        • 9.3.3.2.2. By Application
        • 9.3.3.2.3. By End User

10. Middle East and Africa Diagnostic Imaging Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Product Type
    • 10.2.2. By Application
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Diagnostic Imaging Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Product Type
        • 10.3.1.2.2. By Application
        • 10.3.1.2.3. By End User
    • 10.3.2. Saudi Arabia Diagnostic Imaging Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Product Type
        • 10.3.2.2.2. By Application
        • 10.3.2.2.3. By End User
    • 10.3.3. UAE Diagnostic Imaging Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Product Type
        • 10.3.3.2.2. By Application
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Recent Development
  • 12.2. Mergers & Acquisitions
  • 12.3. Product Launches

13. Global Diagnostic Imaging Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Business Overview
  • 15.2. Service Offerings
  • 15.3. Recent Developments
  • 15.4. Key Personnel
  • 15.5. SWOT Analysis
    • 15.5.1. GE Healthcare Inc.
    • 15.5.2. Philips Healthcare Informatics Inc.
    • 15.5.3. Hitachi Medical Corporation
    • 15.5.4. Hologic, Inc.
    • 15.5.5. Siemens Healthcare GmbH
    • 15.5.6. Samsung Medison
    • 15.5.7. Shimadzu Corporation
    • 15.5.8. Toshiba Medical Systems Corporation
    • 15.5.9. Esaote S.P.A
    • 15.5.10. Fujifilm Corporation

16. Strategic Recommendations

17. About Us & Disclaimer